Recent

% | $
Quotes you view appear here for quick access.

Penn Virginia Corporation Message Board

me2yousee 80 posts  |  Last Activity: 8 hours ago Member since: Feb 25, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • me2yousee by me2yousee May 10, 2016 4:34 PM Flag

    Wow. Looks like the only black cloud tomorrow is going to be shorts going up in smoke. Somebody better call 911 and request responders have burn training.

    Sentiment: Strong Buy

  • Reply to

    The Lawyer next to the good Dr.

    by finn.joseph May 6, 2016 6:48 PM
    me2yousee me2yousee May 8, 2016 3:04 PM Flag

    " Am I being overly concerned? Thoughts?"

    Yes. Why have / pay the lawyer if you aren't going to heed his advice?

    Sentiment: Strong Buy

  • Reply to

    I Have a Question for the Doctors in the House

    by me2yousee May 7, 2016 10:58 AM
    me2yousee me2yousee May 8, 2016 7:31 AM Flag

    Thanks, figured that was the idea, but better know for sure.

    Cancer drug companies have the highest burn rates because of the numbers of patients and length of time required for proof of efficacy and the need to possibly pay to maintain current standards of care. And, it's kinda inhumane to do placebo runs which are required by the government agency that wants to prevent placebo's getting to market in the first place. Yet cancer remains the holy grail of "fear diseases" outside of maybe Alzheimer's.

    So this seems like a slam dunk on a fairly large potential scale in the cancer market place. Assuming that the technology does pass muster.

    Sentiment: Strong Buy

  • Reply to

    I Have a Question for the Doctors in the House

    by me2yousee May 7, 2016 10:58 AM
    me2yousee me2yousee May 7, 2016 11:09 AM Flag

    And if that works, it would give doctors a means to run multiple drugs as a plan of attack. Say using an immunotherapy and a chemical means to attack tumors. Seems to me that trying to use an immunotherapy alone, in a body that has been weakened by the cancer, as a sole means of tumor reduction, doesn't pass a common sense test. This way ol'doc can adjust if reduction isn't occurring fast enough.

    Sentiment: Strong Buy

  • After listening to the presentation the other day, I have a question. If TROV's urine testing is that good, could it be used one day as verification testing to support the FDA approval process for NDAs?

    Seems that if you can track efficacy with a patient for FDA approved drugs, that you could also test for the performance of new ones going through the application process. Mush safer and faster to determine efficacy than waiting for death of the patient from a failed trial.

    Sentiment: Strong Buy

  • Reply to

    Silence = Partnership In the Works

    by lrbecke2 Apr 27, 2016 3:42 PM
    me2yousee me2yousee Apr 27, 2016 4:22 PM Flag

    Nope, the winner will be GILD. This could be a MAJOR profit mover for them and they have major cash on hand for the acquisition. And they have nothing in this area to ruin their research since they don't do anything in this area.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 27, 2016 9:32 AM Flag

    Uncle Sam gives discounts for mistakes. All ya gotta do is sell.

    Sentiment: Strong Buy

  • Reply to

    Motley Fool Article

    by wicked_690hp_hellcat Apr 27, 2016 6:22 AM
    me2yousee me2yousee Apr 27, 2016 7:37 AM Flag

    It's the FDA that will say what is needed to be done. And since the FDA has been speaking very often to AVXL, my guess, is the conversation has come up long before this article.

    Even if the FDA were to be unfriendly, there are other strategies to execute. Take existing data to another agency to get approved first that is more .... open and objective, like Japan. They have old people. Quite a bit actually, as a percentage of the population. Launch it there and in other countries that accept the Japanese approval process to produce revenue and gather more data. Then work your way back to the more difficult / complicated agencies. By then, public opinion will be on their side for people desperate to get this. Just think how many congressman want to be able to stay in office longer.

    These "EXPERT" opinions just show how limited the authors are and what agendas they have.

    Sentiment: Strong Buy

  • I can't understand the mentality of retail shorts going after that last dime of an MACD cycle. Especially, with something with THIS potential. Oink, oink. Wake up, can't find news as to why, but they have to start scrambling for shares simply because somebody else is.

    A very high percentage of pre and after market trading, is short related. So one retail short panic buys to another retail short that takes a "better" position. While they laugh and comment against stupid longs, it is the shorts that fuel virtually ALL rocket launches. They simply cannibalize each other for that "magic" position.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 22, 2016 9:38 AM Flag

    Another possibility. There was a new type of analysis being applied to the data. Now ask yourself .... why? Why would AVXL pay more for data processing that isn't necessary under current FDA standards? Or is it because current FDA procedure hasn't developed squat for AD and the FDA wants to try something new?

    Could be at the request of the FDA for a myriad of reasons. All that seem good to me. Look this is ground breaking stuff on a product that really seems to work for patients. The FDA is excited and this may NOT go like any normal FDA approval process. And they could have a gag in place until a determination is made.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 19, 2016 7:11 AM Flag

    They all work at the same place and are cubicle buddies. Each month, one buys a copy of Motor Trend and they pass it around at work. At the end of the day, they take public transportation back to their parents place.

    Sentiment: Strong Buy

  • I expect new ETFs to be created that will be geared to "the head" this fall. The last big Bio theme was Immunotherapy for Cancer. Before that , it was gene therapy. Any bio that had anything to do in that area caught fire in the fall of 2014 and ZOOMMED up. IPO's came public. CALA tripled in a week. ADXS that had been out for awhile, went from low digits to $30. When the novelty of that sector dies, (using an already weakened body to fight it's own battle with cancer) so did the individual company stocks.

    Guess what, head diseases have numbers of patients that dwarf everything else. And now we are learning that many may be related. Head disease companies have lower burn rates for cash. Results can be measured / tracked inexpensively over reasonably short periods of time compared to other disease. And the FDA is receptive in this area for something that works. And the Government may start dolling out cash in this area too.

    The Heptares example is going to bring IPO's out by this fall. And that will get the ETF ball rolling. So while we have AVXL as an individual company, we may just get some extra market assistance in the months ahead. Don't forget the unpredictable events that might hit the stock outside of AVXL's control too. The Michael J. Fox tests come to mind as an example. Third party news like that, the FDA, and others will raise AVXL's credibility and price eventually.

    Sentiment: Strong Buy

  • We always get that noon time siesta till about 2:30. If they buy through it, could be a LOT more. That'll tell ya if this is a new ballgame (revaluation) or the same ol, same ol.

    Sentiment: Strong Buy

  • me2yousee me2yousee Apr 8, 2016 9:04 AM Flag

    Yep, feed the gap. Rocket fuel is always appreciated.

    Sentiment: Strong Buy

  • Gaps are OK if they are of the break away variety.

    Now that we have a pipeline, AVXL should merit a higher market cap. At least 500 million for 2 multi billion dollar drugs.

    Sentiment: Strong Buy

  • Reply to

    FDA - Orphan Drug Act

    by red.birdfriend Apr 8, 2016 7:34 AM
    me2yousee me2yousee Apr 8, 2016 7:53 AM Flag

    Dumb FDA. Granted AVXL this for a sugar pill? :)

    Sentiment: Strong Buy

  • The shorts goin up in smoke.

    Now we gots us a pipeline for our 200 million market cap.

    Sentiment: Strong Buy

  • Reply to

    My take on AVXL.

    by sciencefan1 Apr 6, 2016 12:55 PM
    me2yousee me2yousee Apr 8, 2016 7:18 AM Flag

    I just had a GREAT idea. Maybe we could put the sugar pill IN the cup of coffee and get a greater effect !!! Right.

    Sentiment: Strong Buy

  • Reply to

    My take on AVXL.

    by sciencefan1 Apr 6, 2016 12:55 PM
    me2yousee me2yousee Apr 8, 2016 7:11 AM Flag

    Yep, and now the FDA, after reviewing our data, granted orphan status for our sugar pill and cup of coffee.

    Sentiment: Strong Buy

  • Reply to

    My take on AVXL.

    by sciencefan1 Apr 6, 2016 12:55 PM
    me2yousee me2yousee Apr 7, 2016 6:02 AM Flag

    You think you are angry now, just wait until a couple of years from now when you say "I once owned AVXL and sold it."

    Sentiment: Strong Buy

PVA
0.000(0.00%)